Clinical Research at Georgia Urology

Shaping the Future of Medicine

Clinical research is essential to medical progress, testing new treatments, drugs, and devices to improve patient care. It is a structured process to evaluate new treatments or methods for safety and effectiveness, following strict protocols to protect participants. It brings innovative therapies to patients and advances healthcare, improving outcomes for all. At Georgia Urology, we are committed to conducting safe, impactful studies that help shape the future of medicine.

Phases of Clinical Trials

Phase 1: Tests safety in a small group of people.
Phase 2: Expands testing to a larger group to assess effectiveness.
Phase 3: Compares the new treatment to standard therapies on a larger scale.
Phase 4: Continues monitoring for long-term effects after approval.

Research Transforms Care

Access to New Treatments: Clinical research allows patients to access new and innovative treatments that are not yet widely available, providing a valuable care option, especially for those with limited treatment alternatives.

Improving Quality of Life: Many studies focus on treating diseases and enhancing quality of life by managing symptoms and improving patients’ comfort.

Advancing Medical Knowledge: Research helps healthcare providers understand diseases more deeply, leading to more accurate diagnoses, targeted therapies, and personalized care plans.

Setting New Standards: Treatments proven effective through research can become part of standard practice, benefiting future patients across the healthcare system.

Faster Innovation in Healthcare: Clinical research accelerates innovation by exploring the effectiveness of emerging therapies and technologies, bringing the latest advancements directly to patients.

At Georgia Urology, we’re dedicated to achieving these goals through expanding research efforts. Every team member, whether directly involved in studies or supporting our mission in other ways, plays a vital role in advancing patient care and the future of urology. Together, we are all part of this journey, shaping the future of healthcare one study at a time.

Meet Our Clinical Research Director

In the dynamic world of clinical research, where innovation shapes the future of healthcare, Dr. Jordan is a strategic leader dedicated to driving transformation. With a strong medical background and a deep commitment to advancing research, equity, and innovation, she seamlessly bridges clinical practice and research to drive efficiency, uphold ethical integrity, and deliver meaningful outcomes.

As an expert in navigating the complex intersection of clinical operations, regulatory strategy, and scientific advancement, Dr. Jordan focuses on optimizing research frameworks that drive efficiency, compliance, and real-world impact.

A passionate advocate for next-generation healthcare solutions, Dr. Jordan is committed to shaping the future of clinical research through innovation, collaboration, and strategic leadership here at Georgia Urology.

Currently Enrolling Studies

Study to Evaluate the Safety and Effectiveness of VNX001 Compared to Placebo, the Individual Components of Lidocaine, and Heparin in Subjects with Interstitial Cystitis/Bladder Pain Syndrome – PI: Dr. Proctor
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States – PI: Dr. Canter
A Phase 2b, Open Label, Single-Arm, Multi-Center, Multiple Dose, 14-Day Study to Evaluate the Safety, Efficacy, and Frequency of Intravesical Administration of VNX001 in Acute Treatment of Subjects with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Who Have an Episode of Acute Bladder Pain of Moderate to Severe Intensity – PI: Dr. Proctor

Successfully Completed Studies

Evaluation of Implantable Tibial Neuromodulation (TITAN 2) Pivotal Study – PI: Dr. Proctor
Composur: A Patient-Centric, Phase IV, Open-Label, Prospective, Real-World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder – PI: Dr. Proctor
Single-Arm, Multi-Center, Prospective Study to Assess the Foramen FinderTM during Peripheral Nerve Evaluation (PNE) – PI: Dr. Capelouto, Sub-I: Dr. Barret-Harlow
A Noninterventional, Retrospective Multi-Center Study to Evaluate the Effectiveness and Safety of XIAFLEX in Adult Male Participants with Ventral Curvature of the Penis Due to Peyronie’s Disease (RETRO-VC) – PI: Dr. Kapadia

Upcoming Studies

A Phase 2, Randomized, Multi-Center, Open-Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy (Gemcitabine and Docetaxel) or Immunotherapy (Pembrolizumab) in Subjects with High-Grade Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer – PI: Dr. Canter
WATER IV Prostate Cancer: Aquablation® Therapy versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer – PI: Dr. Kriteman, Co-I: Dr. Gonzalez
A Pivotal Study of Voro Urologic Scaffold for the Treatment of Post Prostatectomy Stress Urinary Incontinence (ARID II) – PI: Dr. Gonzalez